Bellevue Group AG(0QLZ)
GBP --+0.00%
Reward44Moderate
Risk31Moderate
📊75%Data
Thin 4% profit margin · Revenue down 18% YoY
0QLZ
+0.0 · +0.00%
GBP · LSE
Bellevue Group AG |
Deep Value
Market Cap:112.17M
ℹ️
Reward Rating
44
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
31
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on 0QLZ to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Bellevue Group AG?

Bellevue Group AG engages in the asset management business in Switzerland, the United Kingdom, Germany, and internationally.

0QLZ · Verdict

Moderate reward · moderate risk

0QLZ stands out on balance sheet and valuation, but watch the growth signal.

Based on 88% data coverage

0QLZ · Verdict

What’s working & what to watch

Strengths 3

  • Balance sheet85/100

    Interest covered 12.6×

  • Valuation78/100

    Above average

  • Cash flow76/100

    36% free-cash-flow margin

Watchouts 1

  • Growth23/100

    Rev -18.9% CAGR · earnings -60.8%

Model-based scoring. For information only — not financial advice.

What is Bellevue Group AG?

Bellevue Group AG engages in the asset management business in Switzerland, the United Kingdom, Germany, and internationally. The company offers healthcare investment solutions, including biotech, medtech, thematic, and healthcare global and regional. The company is listed on the LSE in UK, with a market capitalisation of 112.17M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue growth is subdued, limiting near-term earnings expansion.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: Moderate (44)

The scoring profile indicates limited reward potential at this time, with valuation and profitability offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorN/A
Market Cap112.17M
P/E Ratio0.024
Dividend Yield1.92%
52 Week High12.2978
52 Week Low7.0587
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares Outstanding13M
No. of Employees84
IndustryN/A
ExchangeLSE
Beta0.893
CurrencyGBP